Sheffield Local Optometric Committee

Ocular adverse effects with Bisphosphonate

The following was taken from an article by Ian Hutchison, Clinical practice pharmacist at SY&B clinical support unit

There appears to be a link between bisphosphonate use and an increased risk of UVEITIS and SCLERITIS.
Bisphosphonates are used for treatment and prevention of Osteoporosis. In most cases the condition developed rapidly following initiation of therapy.

The oral bisphosphonate medicines prescribed in the UK are:

alendronate (brand names Fosamax, Fosamax Once Weekly, Fosavance) sodium clodronate (Bonefos, Loron) disodium etidronate (Didronel, Didronel PMO) ibandronate (Bondronat, Bonviva) risedronate sodium (Actonel, Actonel Once a Week) disodium tiludronate (Skelid)

Next Meeting:

Copthorne Hotel
Bramall Lane
S2 4SU

at 19:00 Tuesday 30th of April 2019 - AGM

Mailing List

Join our mailing list